GenEng News  Apr 20  Comment 
UCB said today it has acquired rights to Proximagen’s NDA-bound anti-epilepsy candidate Midazolam Nasal Spray (USL261)1 for up to $370 million. Midazolam is being developed as a rescue treatment for acute repetitive seizures (ARS, also known...
GenEng News  Apr 5  Comment 
Reflecting growing interest in developing targeted therapies using genomic insights, UCB said today it has acquired Duke University spinout Element Genomics for up to $30 million. UCB said the deal was designed to strengthen its genomics and...
FierceBiotech  Mar 19  Comment 
Immuno-oncology biotech Five Prime has outlicensed a medication from its protein discovery platform exclusively to Belgium biopharma UCB.
SeekingAlpha  Feb 22  Comment 
FiercePharma  Feb 16  Comment 
Neurology-focused Biogen and UCB are already rumored to be eyeing an Acorda buyout. But one analyst thinks a host of other major players could join their ranks.
MedPage Today  Feb 13  Comment 
(MedPage Today) -- Study addresses mismatch between clinical practice and regulatory approval
FiercePharma  Jan 19  Comment 
Earlier this month, reports said Acorda could be scouting buyers. And now, rumors are swirling as to who those potential bidders might be.
The Hindu Business Line  Dec 15  Comment 
Punjab and Maharashtra Co-op Bank is offering loans at rates lower than that of its bigger rivals

You may also be interested in articles related to UCB SA (UCB-BT):
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki